1. A Phase I/II Study of a 72-h Continuous Infusion of Etoposide in Advanced Soft Tissue Sarcoma. (1997) Authors: Crawley, Charles R.; Judson, Ian R.; Verrill, Mark; Hill, Catherine; Raynaud, Florence I. Journal: Sarcoma Issue: Volume 1:Number 3/4(1997) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. Issue 7 (July 2017) Authors: Cameron, David; Morden, James P; Canney, Peter; Velikova, Galina; Coleman, Robert; Bartlett, John; Agrawal, Rajiv; Banerji, Jane; Bertelli, Gianfilippo; Bloomfield, David; Brunt, A Murray; Earl, Helena; Ellis, Paul; Gaunt, Claire; Gillman, Alexa; Hearfield, Nicholas; Laing, Robert; Murray, Nichol... Journal: Lancet oncology Issue: Volume 18:Issue 7(2017:Jul.) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant Subcutaneous Trastuzumab for HER2‐Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study. (17th July 2018) Authors: Jung, Kyung Hae; Ataseven, Beyhan; Verrill, Mark; Pivot, Xavier; De Laurentiis, Michelino; Al‐Sakaff, Nedal; Lauer, Sabine; Shing, Mona; Gligorov, Joseph; Azim, Hamdy A. Journal: Oncologist Issue: Volume 23:Number 10(2018) Page Start: 1137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Concept: A randomised multicentre trial of first line chemotherapy comparing three weekly cabazitaxel versus weekly paclitaxel in HER2 negative metastatic breast cancer. (December 2022) Authors: Bahl, Amit; Wilson, William; Ball, Jessica; Renninson, Emily; Dubey, Sidharth; Bravo, Alicia; Foulstone, Emily; Spensley, Saiqa; Bowen, Rebecca; Mansi, Janine; Waters, Simon; Riddle, Pippa; Wheatley, Duncan; Stephens, Peter; Bezecny, Pavel; Madhusudan, Srinivasan; Verrill, Mark; Braybrooke, Jerem... Journal: Breast Issue: Volume 66(2022) Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer. (March 2016) Authors: Cresti, Nicola; Lee, Joanne; Rourke, Emma; Televantou, Despina; Jamieson, David; Verrill, Mark; Boddy, Alan V. Journal: European journal of cancer Issue: Volume 55(2016) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HER2 testing in patients with breast cancer. (11th June 2012) Authors: Dixon, J Michael; Wilson, Victoria; Verrill, Mark; Symmans, W Fraser Journal: BMJ Issue: Volume 344(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Metastatic disease of the breast and local recurrence. Issue 1 (January 2016) Authors: Verrill, Mark Journal: Surgery Issue: Volume 34:Issue 1(2016) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P007. Radiological versus pathological response of the axilla to neoadjuvant chemotherapy: Assessing the accuracy of MRI response prediction. Issue 5 (May 2019) Authors: McLean, Ross; Pieri, Andrew; Verrill, Mark; Cresti, Nicola; Cain, Henry Journal: European journal of surgical oncology Issue: Volume 45:Issue 5(2019) Page Start: 887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P015. Outcomes following neoadjuvant chemotherapy for breast cancer: pathological response in the axilla. Issue 5 (May 2019) Authors: McLean, Ross; Cain, Henry; Frost-Younger, Alexander; Amorginos, Petros; Verrill, Mark; Cresti, Nicola; Amonkar, Sunil; Pieri, Andrew Journal: European journal of surgical oncology Issue: Volume 45:Issue 5(2019) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P086. Pathological response in the breast following dual anti-HER2 neoadjuvant chemotherapy for breast cancer. Issue 5 (May 2019) Authors: McLean, Ross; Pieri, Andrew; Cresti, Nicola; Verrill, Mark; Cain, Henry Journal: European journal of surgical oncology Issue: Volume 45:Issue 5(2019) Page Start: 908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗